Vinorelbine plus 3-weekly trastuzumab in metastatic breast cancer: a single-centre phase 2 trial

doi:10.1186/1471-2407-7-50

BMC Cancer

Volume 7

Viewing options:

Associated material:

Related literature:

Articles citing this article
on Google Scholar
on ISI Web of Science
on PubMed Central
Other articles by authors
on Google Scholar

De Maio E
Pacilio C
Gravina A
Morabito A
Di Rella F
Labonia V
Landi G
Nuzzo F
Rossi E
Silvestro P
Botti G
Di Bonito M
Curcio MP
Formichelli F
La Vecchia F
Staiano M
Maurea N
D'Aiuto G
D'Aiuto M
Thomas R
Signoriello G
Perrone F
de Matteis A

on PubMed

De Maio E
Pacilio C
Gravina A
Morabito A
Di Rella F
Labonia V
Landi G
Nuzzo F
Rossi E
Silvestro P
Botti G
Di Bonito M
Curcio MP
Formichelli F
La Vecchia F
Staiano M
Maurea N
D'Aiuto G
D'Aiuto M
Thomas R
Signoriello G
Perrone F
de Matteis A
Related articles/pages
on Google

on Google Scholar

on PubMed

Tools:

Post to:

Email this article to a friend

Vinorelbine plus 3-weekly trastuzumab in metastatic breast cancer: a single-centre phase 2 trial

Ermelinda De Maio , Carmen Pacilio , Adriano Gravina , Alessandro Morabito , Francesca Di Rella , Vincenzo Labonia , Gabriella Landi , Francesco Nuzzo , Emanuela Rossi , Pasqualina Silvestro , Gerardo Botti , Maurizio Di Bonito , Maria Pia Curcio , Franca Formichelli , Franca La Vecchia , Maria Staiano , Nicola Maurea , Giuseppe D'Aiuto , Massimiliano D'Aiuto , Renato Thomas , Giuseppe Signoriello , Francesco Perrone and Andrea de Matteis

BMC Cancer 2007, 7:50doi:10.1186/1471-2407-7-50

Your name*
Your email address*
Recipient's email address*	(multiple email addresses should be separated with commas)
Email format
Please type your message into the box below:	I thought the following article from BMC Cancer (http://www.biomedcentral.com/home) would be of interest to you.